The 16,400-square-foot facility will initially be able to produce 30 tons of 8 types of API for medicines per year with 23 of those tons slotted for export, the Jakarta Post reported. The plant will also produce 7 types of high function chemicals annually for use in cosmetics and food supplements.
Indonesia may allow higher foreign investment in drug companies as Kalbe Farma and state-run Kimia Farma move to build active pharmaceutical ingredient plants to combat persistent raw material shortages.
Indonesia is working to bolster its domestic drugmaking and state-controlled drugmaker Kimia Farma has a list of projects in the works to help that happen. Its most recent is to build a manufacturing facility that will boost its production of herbal medicines.
Indonesia market expanding but local producers can`t keep up